137
Views
19
CrossRef citations to date
0
Altmetric
Review

Neuropsychiatric disturbances in atypical parkinsonian disorders

, , , , , & show all
Pages 2643-2656 | Published online: 09 Oct 2018

References

  • StamelouMHoeglingerGUAtypical parkinsonism: an updateCurr Opin Neurol201326440140523812308
  • StamelouMBhatiaKPAtypical parkinsonism: diagnosis and treatmentNeurol Clin2015331395625432722
  • KerteszAMcmonaglePBehavior and cognition in corticobasal degeneration and progressive supranuclear palsyJ Neurol Sci20102891–213814319733862
  • LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339b270019622552
  • GilmanSLowPAQuinnNConsensus statement on the diagnosis of multiple system atrophyJ Neurol Sci19991631949810223419
  • KrismerFWenningGKMultiple system atrophy: insights into a rare and debilitating movement disorderNat Rev Neurol201713423224328303913
  • GilmanSWenningGKLowPASecond consensus statement on the diagnosis of multiple system atrophyNeurology200871967067618725592
  • PappMILantosPLAccumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophyJ Neurol Sci199210721721821314292
  • PiloLRingHQuinnNTrimbleMDepression in multiple system atrophy and in idiopathic Parkinson’s disease: A pilot comparative studyBiol Psychiatry19963998038078731521
  • GillCEKhuranaRKHiblerRJOccurrence of depressive symptoms in Shy-Drager syndromeClin Auton Res1999911410212741
  • FetoniVSoliveriPMonzaDTestaDGirottiFAffective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapyJ Neurol Neurosurg Psychiatry199966454154410201434
  • Benrud-LarsonLMSandroniPSchragALowPADepressive symptoms and life satisfaction in patients with multiple system atrophyMov Disord200520895195715782421
  • SchragAGeserFStampfer-KountchevMHealth-related quality of life in multiple system atrophyMov Disord200621680981516502399
  • SchragASheikhSQuinnNPA comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophyMov Disord20102581077108120535826
  • WinterYSpottkeAEStamelouMHealth-related quality of life in multiple system atrophy and progressive supranuclear palsyNeurodegener Dis20118643844621576919
  • SiriCDuerrSCanesiMA cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar typeJ Neural Transm2013120461361823462799
  • KawaiYSuenagaMTakedaACognitive impairments in multiple system atrophy: MSA-C vs MSA-PNeurology20087016 Pt 21390139618413566
  • BalasMBalashYGiladiNGurevichTCognition in multiple system atrophy: neuropsychological profile and interaction with moodJ Neural Transm2010117336937520091064
  • KawaharaYIkedaYDeguchiKSimultaneous assessment of cognitive and affective functions in multiple system atrophy and cortical cerebellar atrophy in relation to computerized touch-panel screening testsJ Neurol Sci20153511–2243025727351
  • CaoBZhaoBWeiQ-QThe Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System AtrophyPLoS One20151010e013977326431430
  • BertramKWilliamsDRVisual hallucinations in the differential diagnosis of parkinsonism: Table 1J Neurol Neurosurg Psychiatry201283444845222228724
  • ColosimoCBakTHBolognaMBerardelliAFifty years of progressive supranuclear palsyJ Neurol Neurosurg Psychiatry201485893894424013274
  • HöglingerGURespondekGStamelouMClinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMov Disord201732685386428467028
  • WilliamsDRde SilvaRPaviourDCCharacteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonismBrain200512861247125815788542
  • MaherERLeesAJThe clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)Neurology1986367100510083714047
  • NathUBen-ShlomoYThomsonRGLeesAJBurnDJClinical features and natural history of progressive supranuclear palsy: a clinical cohort studyNeurology200360691091612654952
  • LitvanIMegaMSCummingsJLFairbanksLNeuropsychiatric aspects of progressive supranuclear palsyNeurology1996475118411898909427
  • LitvanICummingsJLMegaMNeuropsychiatric features of corticobasal degenerationJ Neurol Neurosurg Psychiatry19986557177219810944
  • AarslandDLitvanILarsenJPNeuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s diseaseJ Neuropsychiatry Clin Neurosci2001131424911207328
  • GersteneckerADuffKMastBLitvanIENGENE-PSP Study GroupBehavioral abnormalities in progressive supranuclear palsyPsychiatry Res201321031205121024035530
  • BorroniBAlbericiAAgostiCCossedduMPadovaniAPattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsyInt Psychogeriatr200921346346819323870
  • BakTHCrawfordLMBerriosGHodgesJRBehavioural symptoms in progressive supranuclear palsy and frontotemporal dementiaJ Neurol Neurosurg Psychiatry20108191057105920798203
  • EsmondeTGilesEGibsonMHodgesJRNeuropsychological performance, disease severity, and depression in progressive supranuclear palsyJ Neurol199624396386438892064
  • MenzaMACocchiolaJGolbeLIPsychiatric Symptoms in Progressive Supranuclear PalsyPsychosomatics19953665505547501785
  • BloiseMCBerardelliIRoselliVPsychiatric disturbances in patients with progressive supranuclear palsy: A case-control studyParkinsonism Relat Disord201420996596824954060
  • WienerJMoranMTHautMWCompleted suicide in a case of clinically diagnosed progressive supranuclear palsyNeurodegener Dis Manag20155428929226295722
  • YatabeYHashimotoMKanedaKNeuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinicPsychogeriatrics2011111545921447110
  • NicolettiALucaALucaMObsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential TremorParkinsonism Relat Disord201630363927364040
  • GhoshBCRoweJBCalderAJHodgesJRBakTHEmotion recognition in progressive supranuclear palsyJ Neurol Neurosurg Psychiatry200980101143114519762901
  • PontieriFEAssognaFStefaniASad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson’s diseaseParkinsonism Relat Disord201218787187522595619
  • BorroniBTurlaMBertasiVCognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromesArch Gerontol Geriatr2008471536117765337
  • JosephsKADicksonDWDiagnostic accuracy of progressive supra-nuclear palsy in the Society for Progressive Supranuclear Palsy Brain BankMov Disord20031891018102614502669
  • PapapetropoulosSMashDCVisual Hallucinations in Progressive Supranuclear PalsyEur Neurol200554421721916401896
  • RespondekGStamelouMKurzCThe phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite casesMov Disord20141417581766
  • ArmstrongMJLitvanILangAECriteria for the diagnosis of corticobasal degenerationNeurology201380549650323359374
  • AlexanderSKRittmanTXuerebJHBakTHHodgesJRRoweJBValidation of the new consensus criteria for the diagnosis of corticobasal degenerationJ Neurol Neurosurg Psychiatry201485892592924521567
  • MimuraMWhireRFAlbertMLCorticobasal degeneration: neuropsychological and clinical correlatesJ Neuropsychiatry Clin Neurosci19979194989017535
  • MassmanPJKreiterKTJankovicJDoodyRSNeuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer’s diseaseNeurology19964637207268618672
  • WenningGKLitvanIJankovicJNatural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examinationJ Neurol Neurosurg Psychiatry19986421841899489528
  • GedaYEBoeveBFNegashSNeuropsychiatric features in 36 pathologically confirmed cases of corticobasal degenerationJ Neurop-sychiatry Clin Neurosci20071917780
  • SchragABen-ShlomoYQuinnNPPrevalence of progressive supra-nuclear palsy and multiple system atrophy: a cross-sectional studyLancet199935491921771177510577638
  • MorettiRTorrePAntonelloRMCattaruzzaTCazzatoGCognitive impairment in the lateralized phenotype of corticobasal degenerationDement Geriatr Cogn Disord2005202–315816216088142
  • StankovicIKrismerFJesicACognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study groupMov Disord201429785786724753321
  • SchragASelaiCDavisJHealth-related quality of life in patients with progressive supranuclear palsyMov Disord200318121464146914673883
  • LingHO’SullivanSSHoltonJLDoes corticobasal degeneration exist? A clinicopathological re-evaluationBrain201013372045205720584946
  • SchmeichelAMBuchhalterLCLowPAMesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophyNeurology200870536837318227417
  • BenarrochEEBrainstem in multiple system atrophy: clinicopathological correlationsCell Mol Neurobiol2003234/551952614514012
  • BenarrochEESchmeichelAMParisiJEDepletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophyNeurology200259694494612297588
  • NikolausSAntkeCMüllerHWIn vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementiaBehav Brain Res2009204113119523490
  • PagonabarragaJKulisevskyJStrafellaAPKrackPApathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatmentLancet Neurol201514551853125895932
  • HornykiewiczOShannakKBrain monoamines in progressive supranuclear palsy – comparison with idiopathic Parkinson’s diseaseJ Neural Transm199442219229
  • MurphyKEKaraconjiTHardmanCDHallidayGMExcessive dopamine neuron loss in progressive supranuclear palsyMov Disord200823460761018163454
  • MurleyAGRoweJBNeurotransmitter deficits from frontotemporal lobar degenerationBrain201814151263128529373632
  • RubergMJavoy-AgidFHirschEDopaminergic and cholinergic lesions in progressive supranuclear palsyAnn Neurol19851855235293000280
  • RoyRNiccoliniFPaganoGPolitisMCholinergic imaging in dementia spectrum disordersEur J Nucl Med Mol Imaging20164371376138626984612
  • ShinotohHNambaHYamaguchiMPositron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson’s disease and progressive supranuclear palsyAnn Neurol1999461626910401781
  • HueyEDLeeSBrickmanAMNeuropsychiatric effects of neurodegeneration of the medial versus lateral ventral prefrontal cortex in humansCortex2015731926343341
  • IkedaCYokotaONagaoSCorticobasal degeneration initially developing motor versus non-motor symptoms: a comparative clinicopathological studyPsychogeriatrics201414315216425186621
  • UpadhyayNSuppaAPiattellaMCMRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndromeJ Neurol2016263102022203127411806
  • AbeYKimuraNGotoMAsoYMatsubaraEBrain Perfusion in Corticobasal Syndrome with Progressive AphasiaDement Geriatr Cogn Dis Extra20166113314127195001
  • BhartiKBolognaMUpadhyayNAbnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal SyndromeFront Neurol201781928138322
  • SuppaAdi StasioFMarsiliLPrimary motor cortex LTP/LTD-like plasticity in probable corticobasal syndromeJ Neurophysiol2016115271772726561605
  • KlaffkeSKuhnAAPlotkinMDopamine transporters, D2 receptors, and glucose metabolism in corticobasal degenerationMov Disord200621101724172716773621